Cel Sci (CVM) Assets (2010 - 2026)
Cel Sci (CVM) posted Assets of $21.36 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 5.0% from $20.34 million a year earlier and up 20.6% from the prior quarter.
Cel Sci (CVM) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Cel Sci's Assets came in at $28.16 million, up 4.3% from FY2024.
- Annual Assets shows a five-year compound annual growth rate of -7.0% (FY2020 to FY2025).
- In prior fiscal years, Cel Sci's Assets was $26.99 million in FY2024 (-11.6%), $30.53 million in FY2023 (-39.6%), $50.52 million in FY2022 (-33.4%) and $75.87 million in FY2021 (+87.2%).
- Quarterly Assets has run from a low of $17.71 million in fiscal Q2 2026 to a high of $75.87 million in fiscal Q4 2021 over five years.
- On a year-over-year basis, Assets increased in two of the last eight quarters, with an average decline of 10.7%.
- The strongest year-over-year quarter for Assets in the past five years was fiscal Q4 2021, with growth of 87.2%; the weakest was fiscal Q3 2023, with a decline of 43.2%.
- According to Business Quant data, Assets for the three prior fiscal quarters was $17.71 million (Q2 2026), $22.89 million (Q1 2026) and $28.16 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Cel Sci | 3.11 Mn | -22.54 Mn | - | 21.36 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.36 Mn |
| Mar 31, 2026 | 17.71 Mn |
| Dec 31, 2025 | 22.89 Mn |
| Sep 30, 2025 | 28.16 Mn |
| Jun 30, 2025 | 20.34 Mn |
| Mar 31, 2025 | 21.81 Mn |
| Dec 31, 2024 | 25.70 Mn |
| Sep 30, 2024 | 26.99 Mn |
| Jun 30, 2024 | 24.07 Mn |
| Mar 31, 2024 | 30.05 Mn |
| Dec 31, 2023 | 28.71 Mn |
| Sep 30, 2023 | 30.53 Mn |
| Jun 30, 2023 | 32.32 Mn |
| Mar 31, 2023 | 38.20 Mn |
| Dec 31, 2022 | 44.56 Mn |
| Sep 30, 2022 | 50.52 Mn |
| Jun 30, 2022 | 56.89 Mn |
| Mar 31, 2022 | 64.16 Mn |
| Dec 31, 2021 | 69.67 Mn |
| Sep 30, 2021 | 75.87 Mn |
Cel Sci Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=CVM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "CVM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=CVM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();